RE:RE:RE:RE:Helpful insights Thank you Tickle. Well said, and you accurately highlight the difference in perspectives, and I am ok with your views, when you are rational. You are here as I understand to get some real gains out of that original decision to buy shares. Well guess what, we share that in common.
I have done my due diligence on Pullan, and while we should all be careful due to the past, she and her team brings up the calibre of representation here for us long term, sometimes very frustrated shareholders. I admit I have been extremely frustrated in the past, but I do acknowledge that when Sirona brings on such talent, and that talent has credibility in supporting so many companies get to the finish line, and at the right time when they are going into negotiations, that also means this person can work with a wide range of leaders and perspectives.
I also think there is animal health and anti-viral (to partner on clinical trial) on the nearer term radar, if they can get a quality deal done on any of these three, then the other two will be easier to get through as well. The anti-viral is subject to Geraldine's science and the animal health is subject to the re-engagement of those parties post merger.
Lets hope to celebrate at the Finish Line.